Genmab A/S

GNMSF ·Healthcare, Drug Manufacturers - General, Denmark
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
6-K Oct 23, 2026 6-K
6-K Oct 13, 2026 6-K
6-K Oct 7, 2026 6-K
SCHEDULE 13G Oct 5, 2026
6-K Oct 5, 2026 6-K
6-K Oct 2, 2026 6-K
6-K Sep 29, 2026 6-K
6-K Sep 24, 2026 6-K
6-K Sep 9, 2026 6-K
6-K Sep 9, 2026 6-K
6-K Sep 8, 2026 6-K
SCHEDULE 13G/A Aug 14, 2026
6-K Aug 12, 2026 6-K
6-K Aug 11, 2026 6-K
6-K Aug 6, 2026 6-K
6-K Jul 15, 2026 6-K
6-K Jun 29, 2026 6-K
6-K Jun 17, 2026 6-K
6-K Jun 16, 2026 6-K
6-K Jun 15, 2026 6-K
6-K Jun 15, 2026 6-K
6-K Jun 11, 2026 6-K
6-K May 29, 2026 6-K
SCHEDULE 13G/A May 15, 2026
6-K May 13, 2026 6-K
← Newer Page 1 of 23 · 564 filings Older →